• PCV46 Clinical and Economic Burden of Major Bleeding in Abdominal Surgery Patients

    Nov 1, 2011, 00:00

  • PSS9 The Burden of Age-related Macular Degeneration in the Netherlands

    Nov 1, 2011, 00:00

  • PSY38 Estimating Healthy-Time Equivalents for Migraine Treatment Outcomes from Conjoint Analysis Measures of Patient Preferences

    Nov 1, 2011, 00:00

  • PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PMS27 Retrospective Chart Review to Assess Utilization of Resources and Costs Related to Postmenopausal Osteoporosis Treatment of Patients Without Fractures in Slovenia, Serbia, Slovakia and Bulgaria

    Nov 1, 2011, 00:00

  • PCN9 Adverse Events Among Patients with Metastatic Colorectal Cancer Treated with Monoclonal antibodies in Clinical Practice

    Nov 1, 2011, 00:00

  • PGI10 Analysis of Originator Versus Generic Prescribing of Proton Pump Inhibitors

    Nov 1, 2011, 00:00

  • PHP11 The Use of Methylphenidate in A Group of Patients with Attention Deficit and Hyperactivity Disorder

    Nov 1, 2011, 00:00

  • PHP1 Kenya'S Village Aging insensitivity to Aging Policies

    Nov 1, 2011, 00:00

  • PMD42 Cost-Effectiveness of Using the UGT1A1 Pharmacogenetic Test to Reduce the Incidence of Irinotecan Chemotherapy-related Febrile Neutropaenia

    Nov 1, 2011, 00:00

  • PMH54 Quality of Life as a Predictor of Clinical Outcome- Example in Schizophrenia

    Nov 1, 2011, 00:00

  • PCN192 BIA Results Could Stop Introduction of Cost-Effectiveness Therapy into Standard Treatment - Example from Croatia

    Nov 1, 2011, 00:00

  • PSS28 Economic Burden of Advanced Melanoma- Findings From A Large US Health Insurance Database

    Nov 1, 2011, 00:00

  • PMD75 Patient Self-Testing of Oral Anticoagulation Therapy by CoaguChek® XS System. Rapid Health Technology Assessment in Slovak Health Care Environment

    Nov 1, 2011, 00:00

  • PCV24 Pharmacoepidemiology and Pharmacoeconomic Aspects of Use of ACE Inhibitors in Serbia Compared with Montenegro in 2009

    Nov 1, 2011, 00:00

  • PIN113 A New Framework for Understanding the Impact of Hepatitis C and Its Treatment on Quality of Life

    Nov 1, 2011, 00:00

  • PMH72 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length of Hospitalisation of Patients with Acute Bipolar Mania

    Nov 1, 2011, 00:00

  • PSS4 Longer Term Patient Benefits of Polyquad® Preservative Instead of Benzalkonium Chloride in Prostaglandin Eye Drops- A Microsimulation Model in Ocular Hypertension and Open-Angle Glaucoma

    Nov 1, 2011, 00:00

  • PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)

    Nov 1, 2011, 00:00

  • PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III Trial

    Nov 1, 2011, 00:00

  • PSY57 Waist Circumference and Body Mass Index Recording – A Thin Database Study

    Nov 1, 2011, 00:00

  • PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand

    Nov 1, 2011, 00:00

  • PGI31 The Maintenance of Work-related Productivity During One Year of MMX Mesalamine Treatment for Patients with Quiescent Ulcerative Colitis

    Nov 1, 2011, 00:00

  • PCV78 A Cost-Effectiveness Analysis of Clopidogrel Versus Aspirin in Patients with Atherothrombosis in Greece

    Nov 1, 2011, 00:00

  • PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada- Analyses with the Ramq Database

    Nov 1, 2011, 00:00

  • PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b- A Cost-Effectiveness Analysis for the Portuguese NHS Setting

    Nov 1, 2011, 00:00

  • PGI7 Impact of Complications from Dysphagia on Hospital Charges in the United States

    Nov 1, 2011, 00:00

  • PMS9 Prevalence of Shoulder Osteoarthistis and Treatment in A Large US Managed Care Population

    Nov 1, 2011, 00:00

  • PMS8 Cost-Effectiveness analysis of Etanercept versus Available anti-Tnf and Il-6 Blockers for Treating Rheumatoid Arthritis in Guatemala

    Nov 1, 2011, 00:00

  • PMH46 The Quality of Life of Children With ADHD and their Parents- Results of EQ-5D and Kidscreen-10

    Nov 1, 2011, 00:00

  • ISPOR 3rd Latin America Conference Research Abstracts Author Index

    Nov 1, 2011, 00:00

  • PSY5 Estudio Costo-Efectividad Del Parche De LidocaÍna Como Terapia Adyuvante A Pregabalina Y Gabapentina En El Manejo Del Dolor NEUROPÁtico PERIFÉrico En El Hospital San José De Bogotá D.C. Enero-Diciembre 2010

    Nov 1, 2011, 00:00

  • PSY37 Assessment of the Global Cost of Transfusion in French Orthopedic Surgery Wards

    Nov 1, 2011, 00:00

  • PCN41 Hospital Health Care Costs for the Management of HER2-Positive Breast Cancer with Brain Metastases

    Nov 1, 2011, 00:00

  • PCN138 The Impact of Advanced or Metastasic Non-Small Cell Lung Cancer (NSCLC) Symptoms on Patient Daily Living and Health Related Quality of Life- Final Results

    Nov 1, 2011, 00:00

  • PCV103 Estimating the Impact of Adherence to Allopurinol Therapy on Cardiovascular Outcomes in Gout Patients Using the Health Improvement Network (THIN) General Practice Database

    Nov 1, 2011, 00:00

  • PCN148 Estimating Quality of Life in Advanced Melanoma; A Comparison of Standard Gamble, SF-36 Mapped, and Eortc QLQ-C30 Mapped Utilities

    Nov 1, 2011, 00:00

  • PGI32 An Investigation into the Extensive Spectrum of Agents Used for the Management of Post-Operative Ileus

    Nov 1, 2011, 00:00

  • PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments

    Nov 1, 2011, 00:00

  • PRM26 A Literature Review of Methods Used to Estimate Mean Preference-Based Utilities for Comorbidities Using Published Summary Statistics

    Nov 1, 2011, 00:00

  • PRS55 Further Developments of the Living with Chronic Obstructive Pulmonary Disease (LCOPD)

    Nov 1, 2011, 00:00

  • PCN124 The Impact of Condition Labelling on Health State Values

    Nov 1, 2011, 00:00

  • PGI14 Resource Use and Cost of Hepatitis C Related Care in Belgium

    Nov 1, 2011, 00:00

  • EX3 Incremental Cost of Implementing A Care Program for People with Type 2 Diabetes in Argentina

    Nov 1, 2011, 00:00

  • PGI13 Evaluation of the Clinical and Economic Burden of Chronic Constipation in Belgium

    Nov 1, 2011, 00:00

  • PCN199 An Evaluation of Statistical Methods Used to Analyse Patient-Reported Outcomes (PRO) Data in Published Metastatic Cancer Studies

    Nov 1, 2011, 00:00

  • PRS22 Estimation of Direct and Inderct Costs of COPD in Ukraine- The Pilot Study Results

    Nov 1, 2011, 00:00

  • PCN196 Review of Cost Effectiveness of Trastuzumab in Early Breast Cancer

    Nov 1, 2011, 00:00

  • PCV4 Analisis Costo Efectividad En El Largo Plazo De Los Stents Liberadores De Farmaco vs Stents Convencionales En Pacientes Con Cardiopatia Isquemica En El Imss

    Nov 1, 2011, 00:00

  • PMD20 Cost Analysis of Rechargeable Deep Brain Stimulator in Dystonia

    Nov 1, 2011, 00:00

  • PCN136 Cancer Patients' Perceptions Towards the Integration of Traditional CM) into the Conventional Cancer Treatment- A Qualitative Insight

    Nov 1, 2011, 00:00

  • PMH27 An Economic Analysis of the Impact of Crime and Hospitalisation Associated with Different Interventions for Opioid Abuse in the United Kingdom

    Nov 1, 2011, 00:00

  • PMH19 Cost of Relapse in Schizophrenia in Europe- The Constatre Study

    Nov 1, 2011, 00:00

  • PCN174 Variations in Drug Administration Costs for Stage III/IV NSCLC in Europe

    Nov 1, 2011, 00:00

  • PIH37 The Royal Road or the Middle Way? Public and Patient Preferences for Health Outcomes

    Nov 1, 2011, 00:00

  • CN1 Cost-Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer in Six Latin American Countries

    Nov 1, 2011, 00:00

  • PHP84 Assessing Productivity and Activity Impairment Due to Illness in Poland- Employees Versus Employers View

    Nov 1, 2011, 00:00

  • PRM8 Could Corporate Social Responsibility Predict Pharmaceutical Corporate Financial performance?

    Nov 1, 2011, 00:00

  • PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in Spain

    Nov 1, 2011, 00:00

  • PHP47 AvaliaÇÃo Do Mercado De Antimicrobianos No Brasil- Passo Para ImplantaÇÃo Do Monitoramento E Controle SanitÁrio Em Estabelecimentos FarmacÊuticos

    Nov 1, 2011, 00:00

  • PMD43 An Evidence-Based Microsimulation Model for Chronic Graft versus Host Disease in Spain

    Nov 1, 2011, 00:00

  • PRM31 Data Pooling of Patient-Reported Outcomes in Clinical Trials- Evaluation of Structual Equation Modelling for Assessing Equivalence

    Nov 1, 2011, 00:00

  • PRS40 Cost-Utility of Fluticasone Compared with Beclomethasone and Budesonid in Chronic Obstructive Pulmonary Disease (COPD) in Poland

    Nov 1, 2011, 00:00

  • PND52 Responsiveness of the Multiple Sclerosis International Quality of Life and Short Form-36 Questionnaires to Expanded Disability Status Scale Score Changes in Subjects with Multiple Sclerosis- Final 24-Month Results From An Internationa ...

    Nov 1, 2011, 00:00

  • PMS13 Economic Model of Workplace Impacts of anti-Tnf therapy for Rheumatoid Arthritis in Brazil

    Nov 1, 2011, 00:00

  • PHP16 Waiting Time and Its Implications on the Utilization of Antenatal Services in A Free Service Provision Setting in the Asante Akim North Municipal, Ghana

    Nov 1, 2011, 00:00

  • PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to Placebo

    Nov 1, 2011, 00:00

  • PSY11 Budget Impact Model of Hemophilia a Treatment in Turkey- a Payer'S Perspective

    Nov 1, 2011, 00:00

  • PCV145 Predicting Healthcare Expenditures and Utilization in Patients with Dyslipidemia Using the updated Charlson Comorbidity Index (CCI) and Prior Expenditures

    Nov 1, 2011, 00:00

  • PIN104 Pro's in Evaluating Resource Utilisation and Absenteeism in People Receiving Influenza Vaccination

    Nov 1, 2011, 00:00

  • PHP62 Establish Drugs Optimal Purchase Model

    Nov 1, 2011, 00:00

  • PIN93 Assessment of Knowledge and Awareness of Hepatitis B Among General Public in Pakistan

    Nov 1, 2011, 00:00

  • PHP37 Regional Drug Evaluation in Spain- A Comparison Among Committees

    Nov 1, 2011, 00:00

  • PMD86 A Systematic Review of Economic Evaluations Conducted for Assessment of Genetic Testing Technologies

    Nov 1, 2011, 00:00

  • PR3 Industry Preparedness against German reforms

    Nov 1, 2011, 00:00

  • PMH84 The Cornell-Brown Scale for Quality of Life in Dementia- Spanish Adaptation and Validation

    Nov 1, 2011, 00:00

  • PDB56 Development of a New Measure for Assessing Health Related Quality of Life (HRQOL) in Patients with Primary Hyperparathyroidism (PHPQoL)

    Nov 1, 2011, 00:00

  • PSS30 Assessment of Utility Loss From Diabetic Macular Edema Based on Restore Trial

    Nov 1, 2011, 00:00

  • PCV57 Epidemiological Structure, Socioeconomic Effects and Burden of Disease in Patients with Oral Anticoagulation and Atrial Fibrillation in Austria

    Nov 1, 2011, 00:00

  • PSY9 A Budget Impact Model of Rituximab Introduction in Wegener Granulomatosis Therapies

    Nov 1, 2011, 00:00

  • PCN151 Value of Outcomes Research to Inform Reimbursment Decision-Making Illustrated by an Observational Study in Chronic Lymphocytic Leukemia

    Nov 1, 2011, 00:00

  • PMD85 Sleep Questionnaires Discriminate Between Participants With and Without Overactive Bladder Symptoms

    Nov 1, 2011, 00:00

  • PCV52 Temporal Trends in the Hospital Burden of Atrial Fibrillation and Stroke on Secondary Care Costs in England Between 2006 and 2009

    Nov 1, 2011, 00:00

  • PHP79 What Are the Research Priorities in the Spanish National Health System? A Comparison of Economic Evaluations of Health Care Interventions and Public-Funded Research

    Nov 1, 2011, 00:00

  • RM1 Comparing the Use of Dynamic and Static Infectious Disease Models in Latin America with North America, Europe, Asia and other Regions

    Nov 1, 2011, 00:00

  • PIN46 Cost-Effectiveness and Public Health Impact of Pneumococcal Vaccination in Malaysia

    Nov 1, 2011, 00:00

  • EX2 Health Care Resource Use Among Patients With Bipolar Disorder From Brazil and Venezuela- Subgroup Analysis of Data From A Large Multinational Longitudinal Study (WAVE-BD Study)

    Nov 1, 2011, 00:00

  • PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care- Comparing Infliximab to Methotrexate and Systemic Steroids

    Nov 1, 2011, 00:00

  • PHP94 Analysis of Results of the Reference Pricing of Turkey

    Nov 1, 2011, 00:00

  • PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in Bulgaria

    Nov 1, 2011, 00:00

  • PIN98 Evaluating Optimal Treatment Outcomes of Antiviral Therapy in Hepatitis C for Prior Null Responders in the Era of First Generation Protease Inhibitors

    Nov 1, 2011, 00:00

  • PSS15 Burden of Chronic Tinnitus in Hungary

    Nov 1, 2011, 00:00

  • PCN150 Willingness to Pay for A Reduction in Risk of Treatment Side Effects in Patients with Metastatic Breast Cancer

    Nov 1, 2011, 00:00

  • PMS53 Work Productivity and Productivity Costs of Patients with Ankylosing Spondylitis in the Czech Republic

    Nov 1, 2011, 00:00

  • PSU17 Cost-Effectiveness of DSAEK Versus PK for Corneal Endothelialdisease

    Nov 1, 2011, 00:00

  • PCN51 Health Care Resources and Costs Across Lines of Therapies in Insured Patients with Metastatic Breast Cancer in the United States

    Nov 1, 2011, 00:00

  • PCN14 Systematic Review of Clinical Efficacy and Safety outcomes of Anti-Angiogenic Therapies for Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PRS58 Treatment Outcomes of New Smear Positive Pulmonary Tuberculosis Patients in North East Libya

    Nov 1, 2011, 00:00

  • PIH15 Estimating Herpes Zoster Disease Burden in Germany

    Nov 1, 2011, 00:00

  • PMD22 Economic Evaluation of Amino-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) Test in Patients with Dyspnea attending to Emergency Department (ED) in Spain

    Nov 1, 2011, 00:00

  • PMD72 Mamma Carcinoma – Data analyses and Classification of Treatment in Austria

    Nov 1, 2011, 00:00

  • PMH5 Empirically-Driven Definitions of “Good” “Moderate” and “Poor” Levels of Functioning in the Treatment of Schizophrenia

    Nov 1, 2011, 00:00

  • PCN31 Sequential Treatment of Metastatic Renal Cell Carcinoma with Targeted Therapies- Adverse Events Associated Costs, from the Public and Private Perspectives in Brazil

    Nov 1, 2011, 00:00

  • PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral Olanzapine

    Nov 1, 2011, 00:00

  • PMH17 The Economic and Social Consequences of Schizophrenia Treatment with Seroquel XR® (Quetiapine Prolonged Release Tablets) in Poland- Aanalysis of the Impact on the Health Care System

    Nov 1, 2011, 00:00

  • PMD4 Expert Elicitation to Populate Early Health Economic Models of Medical Diagnostic Devices in Development

    Nov 1, 2011, 00:00

  • PIN6 Clinical Outcomes Analysis Comparing Entecavir with Lamivudine Monotherapy and Lamivudine with “Tenofovir Add-on as Needed” Approach in the Treatment of Chronic Hepatitis B Infection in Turkey

    Nov 1, 2011, 00:00

  • PCN63 Cost-Effectiveness of Sunitinib in Patients with Advanced or Metastatic Pancreatic Neuroendocrine Tumors in Portugal

    Nov 1, 2011, 00:00

  • PIN5 Patient and Clinician Perceived Benefit of Early Consumption of Famciclovir for the Treatment of Herpes Outbreaks

    Nov 1, 2011, 00:00

  • PCN120 The Natural History of Fludarabine-Refractory Chronic Lymphocytic Leukemia Patients Who Fail Alemtuzumab or Have Bulky Lymphadenopathy – A European Perspective

    Nov 1, 2011, 00:00

  • PCN82 Cost-Effectiveness Analysis of Trastuzumab + Docetaxel Versus Docetaxel Alone in the Treatment of HER2+ Metastatic Breast Cancer

    Nov 1, 2011, 00:00

  • PCN6 Impact of 5-HT3 Receptor Antagonist Selection Within Triple Antiemetic Regimens on the Risk of Uncontrolled Chemotherapy-Induced Nausea in Patients with Cancer Treated with Highly Emetogenic Chemotherapy

    Nov 1, 2011, 00:00

  • PUK12 Medical Resource Use in US Patients Diagnosed with Chronic Kidney Disease with and Without Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PMH42 Cost-Utility Analysis of Paliperidone Palmitate Long Acting Injection(PLAI) Versus Oral Atypical Antipsychotics in Non-Adherent Schizophrenia Patients

    Nov 1, 2011, 00:00

  • PCV8 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with Dabigatran Under the Brazilian Private Health Care System Persp ...

    Nov 1, 2011, 00:00

  • PRM65 Should We Aggregate Cost-Effectiveness over an Intervention's Entire Implementation Lifetime?

    Nov 1, 2011, 00:00

  • PCN79 Cost Effectiveness of Erlotinib in First Line Treatment of Advanced Non Small Cell Lung Cancer (NSCLC) in Vulnerable Elderly Patients- An Economical Analysis of a prospective Phase 2 Study (GFPC 0505)

    Nov 1, 2011, 00:00

  • PMS76 Treatment Patterns Among Patients with Shoulder Osteoarthistis

    Nov 1, 2011, 00:00

  • PCV136 Factors Associated with Failing to Achieve Low Density Lipoprotein Cholesterol Goal with Existing Statin Therapy- A Chart Extraction-Based Approach

    Nov 1, 2011, 00:00

  • PMS11 Establishing the Safety of Tumour Necrosis Factor Inhibition (TNF-I) in Rheumatoid Arthritis (RA) from an Analysis of Real World Data

    Nov 1, 2011, 00:00

  • PHP21 Medical Services Cost Influence on the Rationality of New Medical Technology Introduction

    Nov 1, 2011, 00:00

  • PSY13 Efecto de un Programa de Atención Farmacéutica Para Pacientes Con Sobrepeso Y Obesos

    Nov 1, 2011, 00:00

  • PND21 Cost of Alzheimer'S Disease in Romania

    Nov 1, 2011, 00:00

  • PRM10 to Get the Right Price – A Decision Support Method to Optimize Managerial Decisions on Public Funding Price to Apply for

    Nov 1, 2011, 00:00

  • PDB54 HRQoL and Clinical Impact of Mild Patient-Reported Hypoglycaemic Episodes in Five European Countries- Extent of Agreement Between Physician- and Patient-Reported Hypoglycaemic Episodes

    Nov 1, 2011, 00:00

  • PHP34 Pricing Insights Across Therapy Areas and European Countries - A Discussion of International Price References and Implications for Parallel Trade and Prescription Patterns of Pharmaceutical Products

    Nov 1, 2011, 00:00

  • MT1 Impact of the Choice of Prior Distribution on relative Effect Sizes Using Bayesian Network Meta-Analysis

    Nov 1, 2011, 00:00

  • PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population

    Nov 1, 2011, 00:00

  • PRS18 Economic Burden of Cystic Fibrosis in the US- Costs of Care By Disease Severity and Age

    Nov 1, 2011, 00:00

  • PDB18 Australia- Management of the Diabetic Foot with Pedimed® Under Real Use Conditions

    Nov 1, 2011, 00:00

  • PIH17 Burden of Illness in Patients with Neural Tube Defects in Germany

    Nov 1, 2011, 00:00

  • PMS36 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in Colombia

    Nov 1, 2011, 00:00

  • PCV94 Dronedarone is Cost-Effective for the Prevention of Downstream Cardiovascular Morbidity and Mortality in Australian Patients with Atrial Fibrillation

    Nov 1, 2011, 00:00

  • PDB8 Cost-Effectiveness Study of Oral Hypoglycemic Agents in Outpatients Diagnosed with Type-2 Diabetes Attending a Primary Care Public Clinic in Mexico City

    Nov 1, 2011, 00:00

  • PIN102 National Cost Savings from the Brazilian HIV/AIDS Antiretroviral Universal Access Program- Analysis Versus Canada and Australia

    Nov 1, 2011, 00:00

  • PSU27 Fracture Related Treatments After Primary Surgical Interventions of Hip Fracture Eight Years Follow Up

    Nov 1, 2011, 00:00

  • UT2 Update of The Patient-Reported Outcome And Quality Of Life Instruments Database (PROQOLID) Using The FDA Guidance On Pro Measures

    Nov 1, 2011, 00:00

  • PMS6 A Network Meta-analysis of Biologic Treatments in TNF-IR Rheumatoid Arthritis Patients

    Nov 1, 2011, 00:00

  • PMH22 Economic Burden of Attention Deficit Hyperactivity Disorder in Children and Adolescents in Europe

    Nov 1, 2011, 00:00

  • PUK6 BPH Patients Treated with Phytotherapy in Portugal- Results at Six Months

    Nov 1, 2011, 00:00

  • PMS24 The Cost of Care of Rheumatoid Arthritis and Ankylosing Spondylitis Patients in Tertiary Care Rheumatology Units in Turkey

    Nov 1, 2011, 00:00

  • PIN7 The Comparative Efficacy of Telaprevir Versus Boceprevir in Treatment-Naive and Treatment-Experienced Patients with Genotype 1 Chronic Hepatitis

    Nov 1, 2011, 00:00

  • PC2 Estimation of Productivity Costs Using the Friction Cost Method- New Evidence Using National Data

    Nov 1, 2011, 00:00

  • PCN38 Economic Evaluation of Darbepoetin Alpha in the Management of Patients with Chemotherapy Induced Anemia (CIA) in Greece

    Nov 1, 2011, 00:00

  • PSY46 Comparison of Eq-5D and Sf-6D Utilities in Pompe Disease

    Nov 1, 2011, 00:00

  • PSU28 Economic Impact of Stereotactic Radiosurgery for Malignant Intracranial Brain Tumors

    Nov 1, 2011, 00:00

  • PCN145 Measurement Properties of the English and Chinese Versions of the Functional Assessment of Cancer Therapy – Breast (FACT-B) in Asian Breast Cancer Patients

    Nov 1, 2011, 00:00

  • PIH50 quality of Life of Students from the Faculty of Pharmacy at Medical University of Warsaw in 2011

    Nov 1, 2011, 00:00

  • PIN7 COST-Effectiveness Analysis Of Anti-Pneumococcal Vaccines Versus No Vaccination In El Salvador

    Nov 1, 2011, 00:00

  • PGI20 Pharmacoeconomic Study of Glutamine Dipeptide Usage During Total Parenteral Nutrition (TPN)

    Nov 1, 2011, 00:00

  • PDB2 Considerably Increasing Incidence of Severe Hypoglycemia 2007-2010 Versus 1997-2000 – a German Longitudinal Population-Based Study

    Nov 1, 2011, 00:00

  • PDB43 The Economic Impact of Weight Loss in Patients Newly Diagnosed with Type 2 Diabetes Mellitus (T2DM) and Younger Than Fifty in Sweden

    Nov 1, 2011, 00:00

  • PDB39 Cost-Effectiveness of Saxagliptin Compared to Sitagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2011, 00:00

  • PUK15 A Simulation Model of The Effects of Treatments for Secondary Hyperparathyroidism on Mortality

    Nov 1, 2011, 00:00

  • PCV142 A Review of the Primary Care Prescribing of Dabigatran Etexilate and Rivaroxaban in Ireland

    Nov 1, 2011, 00:00

  • PMS8 Prevalence of Clinical Risk Factors for Fractures in the Canadian Multicentre Osteoporosis Study

    Nov 1, 2011, 00:00

  • PSU26 Two-Year Changes in Generic and Obesity-Specific Quality of Life After Gastric Bypass

    Nov 1, 2011, 00:00

  • PMS35 A Cost-Effectiveness Analysis of Denosumab for the Treatment of Post-Menopausal Osteoporosis in Greece

    Nov 1, 2011, 00:00

  • PIN91 Sensitivity of Pro's in Evaluating Adverse Events in People Receiving Influenza Vaccination

    Nov 1, 2011, 00:00

  • PCN9 Economic Evaluation of Panitumumab vs Cetuximab in Patients with Colorectal Carcinoma (CRCM) with Non-Mutated (WILD-TYPE) Kras After Failure of Chemotherapy Regimens in Mexico

    Nov 1, 2011, 00:00

  • PHP69 Can We Increase Hospital Revenue with Different Neuromuscular Blockers? An Analysis of Saving Cost for Hospital Budget with Time Saving Effect of Different Neuromuscular Blockers in Short Operations

    Nov 1, 2011, 00:00

  • PMS44 Cost-Effectiveness of Denosumab in the Treatment of Postmenopausal Osteoporosis in Scotland

    Nov 1, 2011, 00:00

  • PCN89 Public Health Impact of Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Sao Paulo, Brazil Using A Transmission Dynamic Model

    Nov 1, 2011, 00:00

  • PMD70 A Review of the Geographic Variations in the Implant Rate of Transcatheter Aortic Valves in 14 European Countries

    Nov 1, 2011, 00:00

  • PSS1 Ocular Discomfort, Compliance and Intra-Ocular Pressure (Iop) Control in Patients Treated for Glaucoma

    Nov 1, 2011, 00:00

  • PCV20 Duration of Action of Aliskiren in Hypertensive Patients with Diabetes – Implications for Control of Blood Pressure in Real-World Use in Imperfectly Adherent Patients

    Nov 1, 2011, 00:00

  • PCV36 High Dose and Long-Term Safety of Systemic Corticosteroids in the Treatment of Polymylagia Rheumatica and Vasculitis- A Systematic Review

    Nov 1, 2011, 00:00

  • PHP82 A Study Explorating the General Public Perceptions Towards Medicines

    Nov 1, 2011, 00:00

  • PMS3 Impacto Economico De La Osteoporosis Y De Las Fracturas Por Fragilidad En El instituto Mexicano Del Seguro social

    Nov 1, 2011, 00:00

  • PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients- A Within Trial Analysis from the Perspective of the ...

    Nov 1, 2011, 00:00

  • PUK1 Belatacept Versus Tacrolimus- Results of an Indirect Analysis from a Systematic Review of Immunosuppressive Therapies for Kidney Transplant Recipients

    Nov 1, 2011, 00:00

  • PIH34 Patient Reported Reasons for Medication Nonadheren A Survey

    Nov 1, 2011, 00:00

  • PMD51 Cost Savings and Improved Utility through the Use of Florbetaben Beta-Amyloid PET Imaging in Dementia Diagnosis

    Nov 1, 2011, 00:00

  • PMS67 Determining the True Impact of Dupuytren'S Disease- A Qualitative Study

    Nov 1, 2011, 00:00

  • PCN44 Cost-of-Illness Study of Human Papillomavirus Cancers in England

    Nov 1, 2011, 00:00

  • PMD35 Cost-Effectiveness Analysis of the Corail Hip System for Primary total Hip Arthroplasty in Spain

    Nov 1, 2011, 00:00

  • PSS27 We Treat Eyes, Not People- The Systematic Overestimations of Utility in Age-Related Macular Degeneration Models

    Nov 1, 2011, 00:00

  • PMD32 Cost Effectiveness of Cervical Cancer Screening in Serbia- A Comparison of Screening Policies

    Nov 1, 2011, 00:00

  • PHP20 Economic Evaluation of Poison Control Centers- A Systematic Review

    Nov 1, 2011, 00:00

  • PRS76 Systematic Literature Review of Conceptual Models to Inform Economic Modelling in COPD

    Nov 1, 2011, 00:00

  • PIN95 The Impact of Influenza on In- and Outpatients' Health related Quality of Life During the Pandemic Season 2009-2010 in Spain

    Nov 1, 2011, 00:00

  • PND14 Comparing Expected Costs associated with Three Screening Strategies for Cystic Fibrosis Along Spain

    Nov 1, 2011, 00:00

  • PMH26 Direct Cost of Schizophrenia in Quebec, Canada- An Incidence-Based Microsimulation Monte-Carlo Markov Model

    Nov 1, 2011, 00:00

  • PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in Poland

    Nov 1, 2011, 00:00

  • PND51 The Relationship Between Patient-Reported Health-Related Quality of Life and Disability Status Among Patients with Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United Kingdom

    Nov 1, 2011, 00:00

  • PCV79 Economic Evaluation of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin in High Risk Patients Treated for Primary and Secondary Prevention of Cardiovascular Disease in Greece

    Nov 1, 2011, 00:00

  • PRS59 Quality of Life in Severe Persistent Uncontrolled Asthma- Patients and Caregivers in the Spanish Pediatric Population- A Prex Study

    Nov 1, 2011, 00:00

  • PND24 Cost of Symptomatic Drug Therapy in Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PIN71 Pharmacoeconomic Analysis of Treatment of Community-Acquired Pneumonia (CAP)

    Nov 1, 2011, 00:00

  • PRM49 Evaluation of Bivariate Meta-analysis Methods to Synthesise Results of Several Studies with Two Correlated Endpoints

    Nov 1, 2011, 00:00

  • PCV61 are Hospital Costs for Stroke Underestimated in Spain?

    Nov 1, 2011, 00:00

  • PCV114 Preferences for Communication Outcomes Following a Stroke

    Nov 1, 2011, 00:00

  • PHP147 Opinions on Market Access Needs Differ Between Cultures and Stakeholder Sectors – Results of a Survey of ISPOR Delegates

    Nov 1, 2011, 00:00

  • PCN47 Clinical and Economic Burden of Breast Cancer in Japan- A Diagnosis Procedure Combination–Based Claims Database Survey

    Nov 1, 2011, 00:00

  • PHP155 Review of Cost Effectiveness Models of High Budget Impact Drugs

    Nov 1, 2011, 00:00

  • PHP16 Extrapolating Strategic Insights Through Market Segmentation- A Conceptual Framework

    Nov 1, 2011, 00:00

  • PCN13 Treatment of Patients with Multiple Myeloma (TLN-Registry)- A “Real Life” Overview of Treatment by Office-Based Oncologists in Germany

    Nov 1, 2011, 00:00

  • PCN40 Health Care Resources Utilization and Costs in Metastatic Melanoma

    Nov 1, 2011, 00:00

  • PRS21 Resource Utilization and Associated Costs of Community Acquired Pneumonia (CAP) in Adults- Observational Study in a Population Setting in a Well Defined Area of Barcelona (Badalona, Spain)

    Nov 1, 2011, 00:00

  • PHP91 Patient Safety Activities Associated with Hospital Pharmacy in A Nationwide Survey on Management System for Patient Safety

    Nov 1, 2011, 00:00

  • PC4 Health Services Utilization, Work absenteeism and Costs of Pandemic influenza A (H1N1)

    Nov 1, 2011, 00:00

  • PCN69 Cost-Effectiveness Analysis of Rituximab Maintenance Treatment of Follicular Lymphoma in Patients Responding to First-Line Inmunochemotherapy Induction

    Nov 1, 2011, 00:00

  • TP1 Prevalence of Lipid Abnormalities Before and After Introduction of Lipid Modifying Therapy Among Mexican Patients

    Nov 1, 2011, 00:00

  • PIN9 Systematic Review of Non-Interferon Based Regimens for Chronic Hepatitis C Treatment

    Nov 1, 2011, 00:00

  • PCV126 Multidimensional Non-Interventional Study to Assess Current Practice, Utilization of Resources and Costs Related to Anticoagulation Treatment in Poland – “Economedica”

    Nov 1, 2011, 00:00

  • DA1 Artificial Neural Network Meta-Models in Cost-Effectiveness analysis of intensive Blood-Glucose Control- A Case Study Applied to the UK prospective Diabetes Study (UKPDS) Individual Patient outcome Simulation Model

    Nov 1, 2011, 00:00

  • PIN14 Prescribing Patterns of Sebivo® (Telbivudine)- A Survey Among Physicians in Selected European Countries

    Nov 1, 2011, 00:00

  • PRS43 Pharmacoeconomic Evaluation of Antibiotic Therapy of Community-Acquired Infections of the Lower Respiratory Tracts By the Use of Moxifloxacin Versus Clarithromycin in Ukraine

    Nov 1, 2011, 00:00

  • PCN16 Disease Burden and Treatment outcomes in Second-Line Therapy of Patients with Estrogen-Receptor Positive (ER+) Advanced Breast Cancer- A Review of the Literature

    Nov 1, 2011, 00:00

  • PMS41 Assessing the Cost Effectiveness of Broadening Access to Alendronate for the Prevention of Osteoporotic Fracture in Australia

    Nov 1, 2011, 00:00

  • PIH43 Changes in Health-Related Behaviours and their Impact on Academic Achievement and Health-Related Quality of Life (HRQOL) Among Spanish Adolescents

    Nov 1, 2011, 00:00

  • PDB38 Economic Evaluation of Ranibizumab in the Treatment of Visual Impairment Due to Diabetic Macular Edema in Austria

    Nov 1, 2011, 00:00

  • QA2 Analisis De Costo-Utilidad De Rituximab Posterior Al Fallo Por Anti-Tnf En Artritis Reumatoide Para Colombia

    Nov 1, 2011, 00:00

  • PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant Therapy

    Nov 1, 2011, 00:00

  • PMH36 Cost-Effectiveness of Depot Flupentixol Versus Long-Acting Risperidone – A Markov Model Parameterized Using Administrative Data

    Nov 1, 2011, 00:00

  • PCV51 Cost of Acute Coronary Syndrome in Switzerland

    Nov 1, 2011, 00:00

  • PCV14 Mixed Treatment Comparison of Dronedarone, Amiodarone and Sotalol for the Management of Atrial Fibrillation in Australia

    Nov 1, 2011, 00:00

  • PRM39 Identification of Diseases for EQ-5D Bolt-on Item Development- An Empirical Approach

    Nov 1, 2011, 00:00

  • PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) Perspective

    Nov 1, 2011, 00:00

  • PCN57 Cost of Treatment of Multiple Myeloma in Ukraine

    Nov 1, 2011, 00:00

  • PND67 A Mixed-Effects Piecewise Linear Model of the Rate of Lung Function Decline Before and After the Clinical Use of Dornase Alfa in an Observational Study of Cystic Fibrosis

    Nov 1, 2011, 00:00

  • PND66 Cross-Cultural Adaptation and Validation of the Brazilian Version of the Fatigue Severity Scale (FSS)

    Nov 1, 2011, 00:00

  • PSU7 Implications of Alloarthroplastic Infections in Hip and Knee Surgery

    Nov 1, 2011, 00:00

  • PRS37 The Impact of Regional Data on Cost-Effectiveness Results of Salmeterol/Fluticasone Propionate (SAL/FP) + Fenoterol/Ipratropium Bromide (Fen/IB) Versus Fen/IB Only in COPD Treatment

    Nov 1, 2011, 00:00

  • PCN72 Cost - Effectiveness Analysis of Cervical Cancer Vaccination Strategies in Spain

    Nov 1, 2011, 00:00

  • PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients with Overactive Bladder in the United Kingdom

    Nov 1, 2011, 00:00

  • PSU19 the Doors-Study of On-Pump Versus Off-Pump Coronary Artery bypass Grafting- A Post Hoc Analysis of Methods for Multiple Imputation of Missing Data in Economic Evaluation

    Nov 1, 2011, 00:00

  • PHP158 Determining the Monetary Value of a Quality-Adjusted Life Year (QALY)- Systematic Review of the Evidence

    Nov 1, 2011, 00:00

  • HT4 What Determines the Recommendations Issued by Polish Health Technology Agency (AHTAPol)?

    Nov 1, 2011, 00:00

  • PMH2 The Efficacy of the New Antidepressant Agomelatine as Compared Against Placebo and SSRIS- A Meta-Analysis Combining Published and Unpublished Data

    Nov 1, 2011, 00:00

  • PHP88 Societal Unmet Needs within Spain

    Nov 1, 2011, 00:00

  • RS2 Cost-Effectiveness of End-of-Life, Life-Extending Interventions- NICE's Cost-Effectiveness Threshold Explored

    Nov 1, 2011, 00:00

  • PDB28 The Roleof Diabetes and Body Mass Index on Medical Expenses, an Analysis of the Medical Expenditure Panel Survey, 2008

    Nov 1, 2011, 00:00

  • PCN161 The Lost Art of Needs Assessment- The Case of Hepatocellular Carcinoma (HCC) Control in European Countries

    Nov 1, 2011, 00:00

  • PRM28 Bayesian Inference in Mixed Treatment Comparisons (MTC) with Continuous Outcomes

    Nov 1, 2011, 00:00

  • PCN103 The Adjuvant Treatment of Stage 3 Colon Cancer (aCC)- An Indirect Cost-Minimisation and Population Net Health Benefit Analysis of Capecitabine + Oxaliplatin (XELOX) vs. iv 5-FU + FA + Oxaliplatin (FOLFOX)

    Nov 1, 2011, 00:00

  • PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branc ...

    Nov 1, 2011, 00:00

  • PRS70 Real World Evaluation of Different Smoking Cessation Service Models in England

    Nov 1, 2011, 00:00

  • PSY14 Differences in Outpatient Care Among Fibromyalgia Patients on Duloxetine Versus Pregabalin

    Nov 1, 2011, 00:00

  • PCV3 Estimated Cost of Acute Coronary Syndrome for 2011- Case of Brazil

    Nov 1, 2011, 00:00

  • PND15 Economic Burden of Chronic Migraine in Taiwan

    Nov 1, 2011, 00:00

  • PMH76 Patterns and Determinants of Sickness Absence Among Users of Antidepressants in a Danish Working Population

    Nov 1, 2011, 00:00

  • PHP35 Is Value Based Pricing Executed In Real Life Situation? – Global Perspectives

    Nov 1, 2011, 00:00

  • PHP19 Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition in the OECD?

    Nov 1, 2011, 00:00

  • PMD9 A1CNow® as Ambulatory Monitoring of Glycated Hemoglobin in Diabetic Type 2 (DM2) Patients- Systematic Review

    Nov 1, 2011, 00:00

  • PRS77 Application of Innovative Methods to Identify and Characterize Differential Responders in Clinical Trials of COPD- The Use of Mixture Models

    Nov 1, 2011, 00:00

  • PIN41 Cost-Benefit Analysis of Regional Procured Essential Medicines in the Southern African Development Community (SADC) with a Focus on Access to Antiretroviral Drugs

    Nov 1, 2011, 00:00

  • PRS52 Inpatient Hospital Care or Hospital-At-Home for COPD Exacerbations- A Discrete Choice Experiment

    Nov 1, 2011, 00:00

  • PRS27 Trends in Uk Smoking Cessation Prescription Expenditure Over Time - a Thin Database Study

    Nov 1, 2011, 00:00

  • UT4 Comparison Of The Performance Of EQ-5D and SF-6D In Patients With Chronic Pain –Results From 3 Randomized Controlled Trials

    Nov 1, 2011, 00:00

  • PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term Patients

    Nov 1, 2011, 00:00

  • PMH48 The Spanish Version of the Clinically Useful Depression Outcome Scale- A Valid Instrument to Evaluate Depressive Symptoms in Primary Care

    Nov 1, 2011, 00:00

  • PRS17 Prevalence and Cost of Severe Chronic Hand Eczema Refractory to Topical Potent Corticosteroids

    Nov 1, 2011, 00:00

  • CN1 Mean Versus Median Overall Survival (OS) For Describing Value of New Cancer Therapies- A Case Study

    Nov 1, 2011, 00:00

  • PND26 Estimated Costs of First-Year Monitoring and Administration of Multiple Sclerosis Therapies in the United States

    Nov 1, 2011, 00:00

  • PIN74 A Cost-Effectiveness Analysis of Vaccinating the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Germany

    Nov 1, 2011, 00:00

  • PSY4 Comparison of Infliximab and Ustekimumab for Treatment of Moderate to Severe Psoriasis- a Mixed Treatment Meta-Analysis

    Nov 1, 2011, 00:00

  • PCN56 Are Out-of-Pocket Payments for Oral Oncologic Therapies Too High? Updated Results From A U.S. Claims Data Analysis

    Nov 1, 2011, 00:00

  • PDB31 Cost of Diabetes in Croatia Impact of Complications on the Costs of Type II Diabetes

    Nov 1, 2011, 00:00

  • PIN34 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Vaccination of Dutch Elderly

    Nov 1, 2011, 00:00

  • PCV65 Clinico-Economic Evaluation of Complex Cardiovascular Therapy with Magnesium Orotate in Patients with Chronic Heart Failure Versus Standard Therapy in Ukraine

    Nov 1, 2011, 00:00

  • PRS34 Cost-Effectiveness of Roflumilast (DAXAS®) in the Treatment Of Chronic Obstructive Pulmonary Disease (COPD) in Spain

    Nov 1, 2011, 00:00

  • PHP17 Characteristics of High Cost Ambulatory Drugs in French Health Care System

    Nov 1, 2011, 00:00

  • PMS69 Effectiveness the Treatments with Natural Mineral Water in Low Back Pain for Spondylarthrosis

    Nov 1, 2011, 00:00

  • PIH39 How Do Postmenopausal Women Describe Breast Pain and Breakthrough Bleeding Associated with Hormonal Treatments for Menopausal Symptoms- Qualitative Interviews with Postmenopausal Women in the United States, China, Mexico and Italy

    Nov 1, 2011, 00:00

  • PIH57 Pediatric Daycare in Belgium

    Nov 1, 2011, 00:00

  • PRS7 Estudio De Costo-Efectividad De Beclometasona vs Ciclesonida Como Medicamentos Controladores En El Manejo Del asma En Pacientes Que asisten A Consulta Externa De NeumologÍa Pediátrica En El Hospital Universitario Clínica San Rafael De ...

    Nov 1, 2011, 00:00

  • PDB79 Application of the Subgroup Identification Tool Using a Health Care Database- Treatment Response Heterogeneity in Type II Diabetes

    Nov 1, 2011, 00:00

  • PMD68 Purchasing and Adopting Cardiovascular Devices- A Global Survey

    Nov 1, 2011, 00:00

  • PSU22 Performance of the Functional Assessment of Visual Tasks (VISTAS-18) among Cataract Patients Receiving Monofocal and Multifocal Intraocular Lens Implants

    Nov 1, 2011, 00:00

  • PND41 Predicting EQ-5D Utility Scores from the Huntington quality of Life instrument (H-QOL-I)

    Nov 1, 2011, 00:00

  • VA4 Costo-Efectividad De La Vacuna Contra El Vph Subtipos 16 Y 18 En México

    Nov 1, 2011, 00:00

  • VA2 Cost Effectiveness Analysis of Vaccination Programs With 10-Valent (PCV10) and 13-Valent (PCV13) Pneumococcal Vaccines in Bogotá, Colombia

    Nov 1, 2011, 00:00

  • PIN101 New Insights on the Spread of Influenza Through Agent Based Epidemic Modeling

    Nov 1, 2011, 00:00

  • PIN81 Cost-Effectiveness Analysis of Peg-Interferon Alpha-2A Plus Ribavirin Versus Conventional Interferon Alpha-2A Plus Ribavirin for the Treatment of Chronic Hepatitis C in China

    Nov 1, 2011, 00:00

  • PRM17 Suitability of CLAD-CQR Models for Obtaining QALYs

    Nov 1, 2011, 00:00

  • PCN71 Value of Progression-Free Survival (PFS) in Refractory Non-Small Cell Lung Cancer (NSCLC)- An Exploratory Modeling Analysis

    Nov 1, 2011, 00:00

  • PMS78 Measurement Strategy for Kyphosis- New Evidence from Patients and Physicians

    Nov 1, 2011, 00:00

  • PR2 Value-Based Pricing in the UK- Developing an Evaluation Framework for Burden of Illness

    Nov 1, 2011, 00:00

  • PCN37 Cost-Minimization Analysis of Second-Line Chemotherapy for Non-Small-Cell Lung Cancer (NSCLC)

    Nov 1, 2011, 00:00

  • PMD73 Comparisons of Anaphylactoid Reactions Associated With Different Gadolinium Products and Iodinated Contast Media Using the FDA's Adverse Event Reporting System

    Nov 1, 2011, 00:00

  • PMS19 The Economic Burden of Post-Menopausal Osteoporosis and Related Fractures in Greece

    Nov 1, 2011, 00:00

  • PDB63 Anti-Diabetic Therapeutic Strategies for Type 2 Diabetes Patients with Chronic Kidney Disease in France

    Nov 1, 2011, 00:00

  • PHP32 Lineamientos De Una PolÍtica De investigación En Salud En Chile- Acuerdos De La Comisión Técnica De investigación Sanitaria Para El Plan Nacional De Salud 2011-2020

    Nov 1, 2011, 00:00

  • PSS2 Prevalence, Demographics and Treatment Characteristics of Visual Impairment Due to Diabetic Macular Edema in A Representative Canadian Cohort

    Nov 1, 2011, 00:00

  • PCN61 Impact of Appropriate Treatment Informed by EGFR Mutation Status on Patient Outcomes from Diagnosis to Death in Advanced Non-Small Cell Lung Cancer

    Nov 1, 2011, 00:00

  • PIN76 Cost Effectiveness analysis of Vaccination with 13-Valent (PCV13) and 23-Valent (PPV23) Pneumococcal Vaccines for Senior Adults in Brazil

    Nov 1, 2011, 00:00

  • PCV80 Economic Evaluation of Pravastatin for the Prevention of Coronary Artery Disease in Japan

    Nov 1, 2011, 00:00

  • PCV2 Evaluation of the prophylaxis Patterns and 90 Day outcome Events in Hospitalized Medically Ill Patients

    Nov 1, 2011, 00:00

  • PDB72 The Burden of Hypoglycaemia in Secondary Care in England

    Nov 1, 2011, 00:00

  • PSY8 Two Analgesic Techniques After Cesarean DELIVERY- A COST-Effectiveness Analysis Study

    Nov 1, 2011, 00:00

  • PIN82 Cost-Effectiveness of Atazanavir/R Compared to Darunavir/R in Germany

    Nov 1, 2011, 00:00

  • PMD79 An Evaluation of the Non-invasive Imaging Tests Used in Current Care of Tia and Minor ischemic Stroke in the Netherlands- How Much Practice Variation is There?

    Nov 1, 2011, 00:00

  • PCN74 Cost-Effectiveness Analysis of Chemoprevention for Colorectal Cancer by Low Dose Aspirin in South Korea

    Nov 1, 2011, 00:00

  • PIN21 Clinico-Economic Evaluation of Treatment of Community-Acquired Pneumonia (CAP) Complicated by Sepsis with Moxifloxacin Compared to Ceftriaxone + Azithromycin

    Nov 1, 2011, 00:00

  • PMD50 Cost-Effectiveness of Cardiac resynchronisation therapy for Patients with Moderate-to-Severe Heart Failure

    Nov 1, 2011, 00:00

  • PCV90 Development of an Institutional Cost of Care Model for Anticoagulation Management of Patients with Warfarin Versus Novel Oral Agents

    Nov 1, 2011, 00:00

  • PIH63 The KIGS Quality Insight Program Assessing the Quality of Care for Short Children Treated with Growth Hormone Using the Output from a Large Pharmaco-Epidemiological Survey

    Nov 1, 2011, 00:00

  • PIH1 Comparison of Unintended Pregnancy Rates in Users of 84/7, 21/7, and 24/4 Oral Contraceptive Regimens

    Nov 1, 2011, 00:00

  • PHP6 Cuadro Básico Y CatÁlogo De Medicamentos Del Sector Salud- Es Actualmente Un referente Para Las instituciones PÚblicas Y/O cumple Con Los Objetivos De Su Creación

    Nov 1, 2011, 00:00

  • PGI30 Comparison of Health Related Quality of Life Between Hepatitis, Cirrhosis, Liver Transplantation and Hepatic Carcinoma- Results of the Come Study

    Nov 1, 2011, 00:00

  • PCN17 Correlations Between Surrogate End Points and overall Survival in Advanced or Metastatic Breast Cancer

    Nov 1, 2011, 00:00

  • PSS41 Impact on Quality of Patients With Active and Inactive Psoriasis in Spain

    Nov 1, 2011, 00:00

  • PCV83 A Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome in Greece

    Nov 1, 2011, 00:00

  • PIN2 Safety and Efficacy of Tenofovir as Compared to Other Nucleot(s)ide Analogues in the Treatment of Chronic Hepatitis B – A Systematic review with Mixed Treatment Comparison

    Nov 1, 2011, 00:00

  • PHP80 Where A Cheap Medicine is Not the Same as A Generic Medicine- The Belgian Case

    Nov 1, 2011, 00:00

  • PHP17 Mexico'S National and Institutional Essential Medicine Lists

    Nov 1, 2011, 00:00

  • PIN79 Cost-Utility Analysis of Tenofovir in Comparison with Other Nucleoside Analogues (AN) in Chronic Hepatitis B (CHB) Treatment

    Nov 1, 2011, 00:00

  • RS4 The Interim Cancer Drugs Fund - How To Not Spend £50 Million

    Nov 1, 2011, 00:00

  • PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel Therapy

    Nov 1, 2011, 00:00

  • PCV19 Prescription of Angiotensin Converting Enzyme Inhibitors and Hypertension Control in Diabetic Hypertensive Patients

    Nov 1, 2011, 00:00

  • PDB60 Health Related Quality of Life of Diabetics in Sindh

    Nov 1, 2011, 00:00

  • HG3 Cost Comparisons and Methodological Heterogeneity in Cost-of-Illness Studies- The Example of Colorectal Cancer

    Nov 1, 2011, 00:00

  • PMD74 Home Dialysis Modalities- The Development of A Framework to Identify and Quantify Favourable Renal Policy and Reimbursement Factors

    Nov 1, 2011, 00:00

  • PMH82 Examining Variability in Depression Among Pre-Retirees- Innovative Analytic Methods Applied to Observational Data

    Nov 1, 2011, 00:00

  • PCV16 Guidelines Adherent Pharmacotherapy Resulted in Better Hypertension Control

    Nov 1, 2011, 00:00

  • PGI21 Cost-Effectiveness of Peginterferon and Ribavirin for Elderly Patients with Chronic Hepatitis C- Results Based on the Nationwide Hepatitis Registration in Japan

    Nov 1, 2011, 00:00

  • PMS13 The Burden of Juvenile Idiopatic Arthritis (JIA) in Russia- A Retrospective Review of Direct and Indirect Costs

    Nov 1, 2011, 00:00

  • PHP114 Performance Indicators of Intensive Care in Hungary

    Nov 1, 2011, 00:00

  • PSY4 Modelo De Costo Beneficio De Lidocaina En Parche Al 5% Versus Pregabalina 300 Mg Y 600 Mg Al Día Para El Tratamiento De La Neuralgia Postherpética

    Nov 1, 2011, 00:00

  • PCN178 Reimbursement of Cancer Drugs in the UK- New Approach to End-of-Llife Treatments and the Technology Appraisal Programme of NICE

    Nov 1, 2011, 00:00

  • PHP26 A SatisfaÇÃo Dos Profissionais De SaÚde vs A SatisfaÇÃo Dos Utentes Em Unidades De Cuidados Continuados

    Nov 1, 2011, 00:00

  • PHP38 Market Access for Pharmaceuticals in UK- Number and Speed of Drug Reviews to Improve After Introduction of Value Based Pricing

    Nov 1, 2011, 00:00

  • PHP89 Detection of Medication Errors in the Thai FDA Database of Adverse Drug Reactions Reports

    Nov 1, 2011, 00:00

  • PCV100 Resource Use in Patients with Acute Coronary Syndrome - an Observational Study Across Secondary and Primary Care in a UK Population

    Nov 1, 2011, 00:00

  • PSS29 Treatment Patterns of Psoriasis Patients and Trends Over Time

    Nov 1, 2011, 00:00

  • PND45 Development and Validation of the Multiple Sclerosis Rating Scale-Revised (MSRS-R)

    Nov 1, 2011, 00:00

  • PHP161 Towards an Efficient National Drug Policy in the Russian Federation

    Nov 1, 2011, 00:00

  • PRS71 Evaluation of the Getquit Clinics for Smoking Cessation

    Nov 1, 2011, 00:00

  • PCN127 Health State Utility Assessment for Breast Cancer

    Nov 1, 2011, 00:00

  • PIN96 Does Connecting Tobacco Cessation Intervention in Tuberculosis Care Improve Quality of Life Outcomes?

    Nov 1, 2011, 00:00

  • PMS1 Meta-analisis De La Efectividad Y Seguridad Del Uso De Celecoxib En El Manejo Del Dolor Cronico vs Otros Cox-2 En Pacientes Con Osteartritis O Artritis reumatoide

    Nov 1, 2011, 00:00

  • PCV131 Cardiovascular Drug Utilization in Relation to Age in Nis Region

    Nov 1, 2011, 00:00

  • MA3 Mapping the Diabetes Health profile (DHP-18) onto the EQ-5D and SF-6D Generic Preference Based Measures of Health

    Nov 1, 2011, 00:00

  • PSY15 Striving for Affordable Treatments Within the Greek Environment- Do Epoetin Biosimilars Help?

    Nov 1, 2011, 00:00

  • PND35 Belgian Cost-Utility Analysis of Gilenya® (Fingolimod) in the Management of Adults with Active Relapsing Remitting Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PCN152 Can Breast Cancer Risk Prediction Reduce the Risks of False Negative and False Positive Screening Mammograms?

    Nov 1, 2011, 00:00

  • MT2 The Use of Continuous Data versus Categorical Data in MTC- The Case of HAQ Multiplier in Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PHP48 Os Motivos Que Levam O JudiciÁrio A Determinar Que Os Planos De SaÚde ForneÇam MedicaÇÃo oral Em Oncologia

    Nov 1, 2011, 00:00

  • PIH56 Performance Assessment of Ga District Mutual Health Insurance Scheme in the Greater Accra Region in Ghana

    Nov 1, 2011, 00:00

  • PUK7 3 Years Follow Up of the Pharmacotherapy Cost of Patients with Kidney Transplantation in Bulgaria

    Nov 1, 2011, 00:00

  • PMD83 Using Five Existing Models to Comprehensively Model the Cost-Effectiveness of A High Definition CT Scanner in A Coronary Artery Disease Population- A Nice Diagnostic Guidance Project

    Nov 1, 2011, 00:00

  • PCN112 Cost-Utility of Treatment for Acute Lymphoblastic Leukemia (ALL) in Childhood

    Nov 1, 2011, 00:00

  • PSS17 Societal Burden of Blindness in Hungary

    Nov 1, 2011, 00:00

  • PDB48 SHORT-Term Cost-Effectiveness of Insulin Detemir Versus NPH Insulin in Insulin-Naïve Subjects with Type 2 Diabetes in Sweden

    Nov 1, 2011, 00:00

  • PMH78 Retrospective Prescription Analysis of Dementia in a South Indian Psychiatric Hopital

    Nov 1, 2011, 00:00

  • ISPOR 3rd Latin America conference disclosure information for reserch presentations

    Nov 1, 2011, 00:00

  • PRS68 A Systematic Review of Chronic Rhinosinusitis in Asia-Pacfic and the Role of Balloon Sinuplasty

    Nov 1, 2011, 00:00

  • PMS12 Evaluacion Economica De Rituximab versus anti-Tnf En Pacientes Con Artritis reumatoide Y Falla Previa A anti-Tnf En México

    Nov 1, 2011, 00:00

  • PRS3 The Effect Of Aat Replacement Therapy on Patient Length And Quality Of Life - a Markov Model

    Nov 1, 2011, 00:00

  • PRM66 Comparison of Reconciliation and Review Methodologies for the Translation of Patient Reported Outcome (PRO) Measures

    Nov 1, 2011, 00:00

  • PCN185 A Multi-Country Retrospective Study of Patient Characteristics and Treatment Patterns in Chronic Myeloid Leukemia

    Nov 1, 2011, 00:00

  • PRS25 Systematic Literature Review of Economic and Humanistic Burden of Dyspnoea in COPD

    Nov 1, 2011, 00:00

  • PRM55 A New Approach to Modeling Cancer Recurrence and Follow-Up

    Nov 1, 2011, 00:00

  • PMS70 Evaluation of Prescribed Pain Medications Prior to the Initiation of Duloxetine Therapy in a Commercially Insured Population

    Nov 1, 2011, 00:00

  • PMS28 Retrospective Chart Review to Assess Utilization of Resources and Costs Related to Postmenopausal Osteoporotic Fractures in Slovenia, Serbia and Bulgaria

    Nov 1, 2011, 00:00

  • PMD12 Economic Impact analysis of Sterilization of Rigid Endoscopes with Sterradtm versus Steam in Spain

    Nov 1, 2011, 00:00

  • PMD14 Budget Impact analysis of Two Drug-Eluting Stents for Diabetic Patients in Spain

    Nov 1, 2011, 00:00

  • PIN100 Why Don't Health Practitioners Prescribe Rationally in Malaria? A qualitative Study from Pakistan

    Nov 1, 2011, 00:00

  • Copyright/Subscription

    Nov 1, 2011, 00:00

  • PCN5 Efectividad CLÍnica Y Costo-Efectividad Del Tratamiento De Segunda LÍnea Para Carcinoma MetastÁsico De CÉlulas Renales

    Nov 1, 2011, 00:00

  • PRS20 Costs of COPD By Disease Severity - a Comparison Over 10 Years

    Nov 1, 2011, 00:00

  • PIN31 Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in Uganda

    Nov 1, 2011, 00:00

  • PMS77 Improving Quality and Reducing Costs in Workers' Compensation Health Care- A Population-Based Intervention Study

    Nov 1, 2011, 00:00

  • PND42 Impact of Relapses Leading to Hospitalisation on Health-Related Quality of Life, Fatigue and Health Care Resource Utilisation in A Population with A Relapsing Form of Multiple Sclerosis (RMS) Using Data from Temso A Teriflunonomide Pi ...

    Nov 1, 2011, 00:00

  • PCV10 Un Estudio De Minimizacion De Costos Para Evaluar El Tratamiento Con Metoprolol En Pacientes Con Hipertension Arterial En México

    Nov 1, 2011, 00:00

  • PRM6 Translation of Patient-Reported Outcomes Measures Translatability Review And Item Definition

    Nov 1, 2011, 00:00

  • PND9 The Role of Spontaneous Events Databases for Benefit-Risk Analysis

    Nov 1, 2011, 00:00

  • PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in Russia

    Nov 1, 2011, 00:00

  • PMD37 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in France

    Nov 1, 2011, 00:00

  • PMH71 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length and Costs of Hospitalisation of Patients with Schizophrenia or Bipolar Disorder

    Nov 1, 2011, 00:00

  • PND1 Estimating Net Health Benefits Of Intramuscular Interferon Beta-1A And Fingolimod In Treating Patients With Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2011, 00:00

  • MT4 Mixed Treatment Comparisons Using Aggregate- and individual-Participant Level Data- An Efficient Use of Evidence for Cost-Effectiveness Modelling

    Nov 1, 2011, 00:00

  • PRM51 Nonparametric Regression Analysis Controls Cost Analysis in Data with Outliers

    Nov 1, 2011, 00:00

  • PDB42 Economic Evaluation of Recombinant Human FSH in Comparison with Urinary HMG in Assisted Reproduction in the Greek Setting

    Nov 1, 2011, 00:00

  • PDB68 The Impact of Implementing a Drug Preauthorization Policy in a Primary Care Setting

    Nov 1, 2011, 00:00

  • PMD71 Resource Use Caused by in-office Follow-up Visits for Cardiac Implantable Electrical Devices (CIED) in Germany and the United Kingdom

    Nov 1, 2011, 00:00

  • PCV5 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with No Treatment Under the Brazilian Private Health Care System Per ...

    Nov 1, 2011, 00:00

  • PHP9 Preditores Da quantidade De Medicamentos Tomados Em Pessoas Com DoenÇa Crónica

    Nov 1, 2011, 00:00

  • PSY9 Evaluación Económica De Dieta Inmunoreguladora (Inmunex Plus®) En Pacientes Mexicanos

    Nov 1, 2011, 00:00

  • PMH56 Negative Symptoms Have Greater Impact on Functioning Than Positive Symptoms in Schizophrenia- Analysis of Catie Data

    Nov 1, 2011, 00:00

  • PND46 The Huntington Quality of Life Instrument (H-QOL-I)- Cross-Cultural Validation in Germany, Poland and USA

    Nov 1, 2011, 00:00

  • PRS60 The Impact of Severe Poor-Controlled Asthma On Patients' Quality of Life Control Study

    Nov 1, 2011, 00:00

  • PDB83 The Epidemiology and Burden of Obesity and Diabetes in Fran A Methodological Comparison

    Nov 1, 2011, 00:00

  • PMD30 Cost-Effectiveness Analysis of Pulmonary Vein Isolation (PVI) Using A Novel Cryo Energy-Based Balloon Catheter- A High-Value procedure for Payers?

    Nov 1, 2011, 00:00

  • PMD13 Cost Analysis of Vascular Closure Devices (VCD) in the United States

    Nov 1, 2011, 00:00

  • PGI25 Chronic Hepatitis C (CHC) Related Flu-like Symptoms; Development of a Patient Report Outcome (PRO) Measure and Results from Pilot Efficacy Studies

    Nov 1, 2011, 00:00

  • PIH44 Health-Related Quality of Life for Patients with Chronic Conditions- Revealing the Profile of Burden Associated with Co-Morbid Physical and Mental Conditions in Respondents from Five European Countries

    Nov 1, 2011, 00:00

  • PMS61 Rapid Reductions in Fatigue and Sleep Problems and Correlation with Improvements in Patient-Reported Outcomes in Patients with Active RA Treated with Certolizumab Pegol in the realistic 12-Week Phase IIIB Randomised Controlled Study

    Nov 1, 2011, 00:00

  • PMH83 Estimating Utilities in Schizophrenic and Bipolar Patients from Disease-Specific or Generic Instruments Assessing Patients' Health States- Where are the Differences?

    Nov 1, 2011, 00:00

  • PRM30 A Comparison of the Patientslikeme Quality of Life Questionnaire (PLMQOL) with the Rand SF-36

    Nov 1, 2011, 00:00

  • PND18 Recent Trends in Muscular Dystrophy-Related Inpatient Care Among Pediatric Patients In The United States

    Nov 1, 2011, 00:00

  • PCV32 Population Attributable Risk (PAR) of Macrovascular Events Associated with HbA1C, Blood Pressure or Weight in Patients with Type 2 Diabetes Mellitus- Evidence from a Dutch Cohort

    Nov 1, 2011, 00:00

  • PCN191 Economic Evaluation of XELOX vs FOLFOX4 as Adjuvant Treatment for Patients with Stage III Colon Cancer in south Korea

    Nov 1, 2011, 00:00

  • PGI2 Cost-Effectiveness Analysis of the Use of Adalimumab for the Treatment of Crohn's Disease (CD) in Mexico

    Nov 1, 2011, 00:00

  • PCV82 Simulation of Long-Term Clinical Benefits and Costs of Add-On Therapy with Aliskiren in Hypertensive Patients with Diabetic Nephropathy- A German Statutory Health Insurance Perspective

    Nov 1, 2011, 00:00

  • PRM15 The Outcome of ISPOR European and International Congresses Between 2005-2009

    Nov 1, 2011, 00:00

  • PCV34 Improving Global Vascular Risk Management (GVRM) Using the COSEHC Cardiovascular Risk Assessment Tool

    Nov 1, 2011, 00:00

  • PIH40 Designing a Disease-Specific Patient Reported Outcome (PRO) for a Rare Disease- Assessing the Reliability, Validity, and Responsiveness of the Hunter Syndrome - Functional Outcomes for Clinical Understanding Scale (HS-Focus)

    Nov 1, 2011, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127 (current)
  • 128
  • 129
  • 130
  • »